Roth Capital Downgrades Clayton Williams Energy (CWEI) to Neutral Feb 27, 2015 12:07PM
Roth Capital Trims PT on Keryx Biopharma (KERX) to $27; 'Blocking and Tacking' w/ Medicare to Ensure Auryxia Success Feb 27, 2015 10:36AM
MoSys (MOSY) Prices 12.5M Common Offering at $1.60/Share Feb 27, 2015 08:51AM
MoSys (MOSY) Poised to Open Lower Following Stock Offering Feb 27, 2015 08:37AM
Roth Capital (SPPI) Comments on Spectrum (SPPI) Following Tentative FDA Approval of Sandoz's Levoleucovorin Calcium Feb 26, 2015 02:24PM
View Older Stories

Feb 26, 2015 12:44PM Roth Positive on Expansion of STAR Study Sites; Afforms Cytori (CYTX) at 'Buy'
Feb 26, 2015 11:01AM Notable Analyst Rating Changes 2/26: (AXP) (TMUS) (JAKK) Upgraded; (PCRX) (CVC) (PGRE) Downgraded
Feb 26, 2015 09:33AM Pre-Open Stock Movers 02/26: (ELX) (CYBX) (UIL) (CRM) Higher; (CLRX) (LKQ) (TASR) Lower (more...)
Feb 26, 2015 08:24AM Lion Biotechnologies (LBIO) Prices 8M Common Offering at $8/Share
Feb 26, 2015 07:10AM Roth Capital Starts Ohr Pharmaceutical (OHRP) at Buy
Feb 25, 2015 12:14PM Roth Tweaks Numbers on Auryxia Ahead of Keryx Pharna's (KERX) Q4 Report; Maintains 'Buy' Rating
Feb 25, 2015 11:40AM Upcoming Milestones, Key Investment Points for Bio Blast Pharma (ORPN) Being Missed by Investors - Roth Capital
Feb 25, 2015 08:10AM Curis (CRIS) Prices 21.8M Common Offering at $2.75/Share
Feb 23, 2015 10:39AM Notable Analyst Rating Changes 2/23: (LH) (PENN) (CL) Upgraded; (BA) (RIG) (DGX) Downgraded
Feb 23, 2015 09:41AM Breakthrough Designation for Celldex's (CLDX) Rintega Points to Stronger FDA Support as Cancer Vaccine in GBM - Roth Capital
Feb 23, 2015 08:36AM Roth Capital Upgrades New Gold (NGD) to Neutral
Feb 23, 2015 07:33AM Roth Capital Starts Flex Pharma (FLKS) at Buy
Feb 23, 2015 07:07AM Roth Capital Starts Zosano Pharma (ZSAN) at Buy
Feb 23, 2015 07:01AM Roth Capital Downgrades Spectrum Pharmaceuticals (SPPI) to Neutral
Feb 20, 2015 10:46AM Notable Analyst Rating Changes 2/20: (MRVL) (DSW) (KN) Upgraded; (FUEL) (HLSS) (REGN) Downgraded
Feb 19, 2015 04:44PM Roth Capital Downgrades Regeneron (REGN) to Neutral; Pipeline Opportunities Largely Priced In
Feb 19, 2015 10:47AM Notable Analyst Rating Changes 2/19: (COH) (VLO) (MWW) Upgraded; (I) (PCYC) (HUN) Downgraded
Feb 19, 2015 09:21AM Pre-Open Stock Movers 02/19: (BJRI) (PCLN) (BBW) Higher; (OCRX) (NLST) (CSLT) Lower (more...)
Feb 19, 2015 08:59AM UPDATE: Roth Capital Cuts Pharmacyclics (PCYC) to Neutral; Sees FY15 Guidance, Market Expectations Priced into Shares
Feb 19, 2015 07:59AM SolarCity (SCTY) May See N-T Weakness on Unfavorable Mix; Roth Maintains 'Buy' Rating
Feb 19, 2015 07:56AM Roth Capital Starts Spark Therapeutics (ONCE) at Buy
Feb 19, 2015 08:59AM UPDATE: Roth Capital Cuts Pharmacyclics (PCYC) to Neutral; Sees FY15 Guidance, Market Expectations Priced into Shares
Feb 18, 2015 08:26AM Roth Capital Boosts Ests on Enphase (ENPH) Following Q4 Numbers, Outlook
Feb 17, 2015 12:11PM Roth Affirms Bio Blast Pharma (ORPN) at 'Buy'; Plenty of Catalysts Ahead in Next 12 - 18 Months
Feb 17, 2015 11:19AM Roth Still Positive on Cytori (CYTX) as ACT-OA Phase 2 Commences
Feb 13, 2015 02:40PM Palatin (PTN) Outpaces Q2 Ests on BMT Program Milestone; Roth Capital Affirms at 'Buy'
Feb 13, 2015 08:29AM Cytokinetics (CYTK) Surpasses FY14 Estimates Following Recent Astellas Deal; Roth Cap. Affirms at 'Buy'
Feb 12, 2015 08:12AM ImmunoCellular Therapeutics (IMUC) Prices Stock and Warrants Offeirng
Feb 12, 2015 08:12AM ImmunoCellular Therapeutics (IMUC) Prices 26.65M Common, 18.66M Warrants Offering
Feb 11, 2015 12:56PM Ohr Pharmaceutical (OHRP) Closes 4.26M Common Offering; Gross Proceeds at ~$28.8M
Feb 11, 2015 12:16PM Streetinsider.com's Hot Lunchtime Reads 2/11: (AAPL) (OC) (IMMR) (FB)
Feb 11, 2015 11:39AM 2015 Expected to be 'Transformative' Year for Applied Genetic Technologies (AGTC) - Roth Capital
Feb 11, 2015 10:37AM Notable Analyst Rating Changes 2/11: (NUS) (NSP) (YELP) Upgraded; (WMT) (XLS) (ATEN) Downgraded
Feb 11, 2015 08:54AM Regeneron (REGN) Misses Q4 GAAP EPS Views on R&D, Pipeline Expansion, but EYLEA Shaping-Up Well - Roth Capital
Feb 11, 2015 08:39AM Delcath Systems (DCTH) Prices 2.46M Common Offering at $1.15/Share
Feb 11, 2015 08:39AM Delcath Systems (DCTH) Prices 2.46M Common Offering at $1.15/Share
Feb 11, 2015 06:50AM Roth Capital Upgrades Insperity (NSP) to Buy
Feb 10, 2015 04:55PM Delcath Systems (DCTH) to Offer Common Stock And Warrants
Feb 10, 2015 09:08AM RedHill Biopharma (RDHL) Prices 1M Offering at $12.50/ADS
Feb 10, 2015 08:33AM Roth Capital Starts CECO Environmental (CECE) at Neutral
Feb 9, 2015 04:46PM RedHill Biopharma (RDHL) Reports Proposed Public Offering of ADS
Feb 9, 2015 07:03AM Roth Capital Starts Vermillion (VRML) at Buy
Feb 6, 2015 10:39AM Notable Analyst Rating Changes 2/6: (IMGN) (FBP) (WWE) Upgraded; (YELP) (P) (VIAB) Downgraded
Feb 6, 2015 10:08AM Roth Cuts PT on Synta Pharma (SNTA) to $20; Still Attractively Priced Given Ganetespib Potential
Feb 6, 2015 08:46AM Ohr Pharmaceutical (OHRP) Prices 3.7M Common Offering at $6.75/Share
Feb 6, 2015 06:43AM Roth Capital Resukmes Acadia Pharmaceuticals (ACAD) at Buy
Feb 4, 2015 09:17AM Roth Positive on Can-Fite Bio Pharma (CANF) Following Completion of CF101 Phase 2/3
Feb 4, 2015 09:04AM Catyalyst Pharmaceutical (CPRX) Prices 10M Shares at $3.25/Share
Feb 4, 2015 08:15AM Tonix Pharmaceuticals (TNXP) Prices 4.9M Common Offering at $5.85/Share
Feb 3, 2015 04:04PM Tonix Pharmaceuticals (TNXP) Plans Common Stock Offering
View Older Stories